approval · primary record
ERAVACYCLINE DIHYDROCHLORIDE
FDA · NDA · 2025-03-31
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-03-31 |
| Brand | XERAVA |
| Sponsor | TETRAPHASE PHARMS |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:52.377Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ERAVACYCLINE DIHYDROCHLORIDE:2025-03-31
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.